文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

迷你支气管肺泡灌洗诊断2019冠状病毒病相关侵袭性肺曲霉病

Mini-Bronchoalveolar Lavage for Diagnosing Coronavirus Disease 2019-Associated Invasive Pulmonary Aspergillosis.
PubMed 文献 · Crit Care Explor · 2021-12-17
一句话结论在ICU疑似COVID-19相关侵袭性肺曲霉病患者中,迷你支气管肺泡灌洗与导向支气管肺泡灌洗的曲霉检测阳性率相似。

本研究为回顾性队列研究,纳入阿姆斯特丹大学医学中心ICU中确诊COVID-19并筛查COVID-19相关侵袭性肺曲霉病的患者76例,其中20例接受支气管肺泡灌洗、40例接受迷你支气管肺泡灌洗、16例两者均接受。支气管肺泡灌洗与迷你支气管肺泡灌洗样本中一项或以上曲霉检测(半乳甘露聚糖、培养、聚合酶链反应)阳性的比例无显著差异(16.7% vs 21.4%)。迷你支气管肺泡灌洗样本中阳性更多由聚合酶链反应驱动(17.9% vs 2.8%;p=0.030)。在同时接受两种灌洗的16例患者中,81%(13/16)结果一致;12例首次迷你支气管肺泡灌洗阴性者中11例(92%)后续支气管肺泡灌洗亦阴性。作者认为迷你支气管肺泡灌洗可能是ICU患者COVID-19相关侵袭性肺曲霉病筛查的有用工具。

要点

  • 在76例确诊COVID-19的ICU患者中,支气管肺泡灌洗与迷你支气管肺泡灌洗样本的曲霉检测(半乳甘露聚糖、培养、聚合酶链反应)任一阳性率无显著差异(16.7% vs 21.4%)。
  • 迷你支气管肺泡灌洗样本中聚合酶链反应阳性率高于支气管肺泡灌洗(17.9% vs 2.8%;p=0.030)。
  • 同时接受两种灌洗的16例患者中,81%(13/16)结果一致。
  • 12例首次迷你支气管肺泡灌洗阴性者中,11例(92%)后续支气管肺泡灌洗亦阴性。
  • 作者认为迷你支气管肺泡灌洗可能是ICU患者COVID-19相关侵袭性肺曲霉病筛查的有用工具。

适用人群与场景

  • 阿姆斯特丹大学医学中心ICU中确诊COVID-19并筛查COVID-19相关侵袭性肺曲霉病的患者。

处置流程与药物剂量

  • 迷你支气管肺泡灌洗和/或导向支气管肺泡灌洗用于曲霉检测(半乳甘露聚糖、培养、聚合酶链反应)。

研究设计与关键结果

  • 研究类型:回顾性队列研究;单中心(阿姆斯特丹大学医学中心ICU);样本量76例,其中20例接受支气管肺泡灌洗、40例接受迷你支气管肺泡灌洗、16例两者均接受。
  • 支气管肺泡灌洗与迷你支气管肺泡灌洗样本中一项或以上曲霉检测阳性的比例无显著差异(16.7% vs 21.4%)。
  • 迷你支气管肺泡灌洗样本中聚合酶链反应阳性率高于支气管肺泡灌洗(17.9% vs 2.8%;p=0.030)。
  • 同时接受两种灌洗的16例患者中,81%(13/16)结果一致。
  • 12例首次迷你支气管肺泡灌洗阴性者中,11例(92%)后续支气管肺泡灌洗亦阴性。

证据类型、等级与局限

  • 证据类型:回顾性队列研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为迷你支气管肺泡灌洗可能是ICU患者COVID-19相关侵袭性肺曲霉病筛查的有用工具。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To evaluate the yield of mini-bronchoalveolar lavage compared with that of directed bronchoalveolar lavage in critically ill patients with suspected coronavirus disease 2019-associated pulmonary aspergillosis.

DESIGN: A retrospective cohort study.

SETTING: The ICU of the Amsterdam University Medical Centers.

PATIENTS: Patients with confirmed coronavirus disease 2019 screened for coronavirus disease 2019-associated pulmonary aspergillosis.

INTERVENTIONS: Mini-bronchoalveolar lavage and/or directed bronchoalveolar lavage.

MEASUREMENTS AND MAIN RESULTS: In total, 76 patients were included, 20 of whom underwent bronchoalveolar lavage, 40 mini-bronchoalveolar lavage, and 16 both mini-bronchoalveolar lavage and bronchoalveolar lavage. The percentage of samples with one or more positive Aspergillus detecting test (galactomannan, culture, polymerase chain reaction) did not differ significantly between bronchoalveolar lavage and mini-bronchoalveolar lavage (16.7% vs 21.4%). However, in mini-bronchoalveolar lavage samples, this was more frequently driven by a positive polymerase chain reaction than in bronchoalveolar lavage samples (17.9% vs 2.8%; p = 0.030). In 81% of patients (13/16) with both mini-bronchoalveolar lavage and bronchoalveolar lavage, the test results were in agreement. In 11 of 12 patients (92%) with first a negative mini-bronchoalveolar lavage, the subsequent bronchoalveolar lavage sample was also negative.

CONCLUSIONS: We found a similar percentage of positive test results in mini-bronchoalveolar lavage and bronchoalveolar lavage samples in patients with suspected coronavirus disease 2019-associated pulmonary aspergillosis. Our findings indicate that mini-bronchoalveolar lavage could be a useful tool for coronavirus disease 2019-associated pulmonary aspergillosis screening in ICU patients.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Vanbellinghen MC, Atasever B, van der Spoel HJI, et al. Mini-Bronchoalveolar Lavage for Diagnosing Coronavirus Disease 2019-Associated Invasive Pulmonary Aspergillosis. Crit Care Explor. 2021. PMID: 34939036. doi:10.1097/CCE.0000000000000601

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。